PeptideStack
5.2kquestions
20kanswers
220users

Which of the canon vendors publish lot-specific documentation?

Asked 3 Aug 2025Modified 10 months agoViewed 21k times
23

The lane and the lead time matter as much as the material for what I am doing.

I have the document in front of me and I can read the numbers. What I cannot do is interpret them.

I am reasonably comfortable with statistics and completely uncomfortable with chromatography, or vice versa.

What is the correct interpretation, and what is the common misreading?

vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
shareeditfollowflag
EH
askedeighty_six_hours20k273 Aug 2025
5Have you ordered yet? The pre-order checks and the post-arrival checks are different lists. – tadhg_o_riordan 3 months ago
add a comment

5 Answers

Accepted answer first, then by votes
53

Accepted answer

The relevant point is that two competent laboratories disagree by half a per cent on identical material, which is larger than most of the differences people argue about.

Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

Lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

The caveat is that a comparison is a snapshot of the lots compared, and lots change.

One laboratory, one method, one submission. Otherwise it is not a comparison.

shareimprove this answerflag
NN
answered · acceptednine_point_nine60k14813 Sept 2025
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
62

A single member running three suppliers on one method is worth more than thirty members running one supplier each.

To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.

Comparisons drawn from different laboratories at different times are weaker evidence than most people treat them as.

Price per milligram of measured peptide, not per milligram of label claim.

shareimprove this answerflag
TO
answeredt_oyelaran79k485 Oct 2025
5Worth adding that legal position and enforcement posture are different things. – mz_4113 7 months ago
add a comment
42

Put another way, ratings on this site are ours alone and are deliberately not reconciled with anyone else's.

Content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.

Stated carefully, submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Use a fixed documentation checklist rather than an impression.

shareimprove this answerflag
NN
answerednine_point_nine60k14824 Sept 2025
7Worth flagging that comparing across laboratories is comparing laboratories, not suppliers. – e_dziedzic 27 days ago
8Thank you — the checklist format makes this actionable rather than merely correct. – priya_menon 3 months ago
add a comment
25

Start by asking what you are optimising for, because cost per milligram, documentation depth and lead time do not have a common winner.

Publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.

Name the laboratory and the dates or the comparison cannot be reproduced.

edited 29 Sept 2025 by drawn_and_capped — expanded the table to cover the lower concentration

shareimprove this answerflag
DC
answereddrawn_and_capped12k172 Sept 2025
23

The short version: same compound, same laboratory, same method, ideally same week — otherwise you are comparing laboratories rather than suppliers.

Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.

Gradient slope, column chemistry and detection wavelength all affect the reported purity figure, which is why the method section is the part that makes results comparable.

Compare content, not purity. Purity clusters and content does not.

shareimprove this answerflag
JW
answeredj_wierzbicki69k14822 Aug 2025
4Small correction: carriage amortises across the order, which changes small-order economics entirely. – h_pergande 1 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.